These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22883542)

  • 21. Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.
    Konijnenberg C; Melinder A
    Child Neuropsychol; 2011; 17(5):495-519. PubMed ID: 21480011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
    Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
    Bandstra ES
    Addiction; 2012 Nov; 107 Suppl 1():1-4. PubMed ID: 23106922
    [No Abstract]   [Full Text] [Related]  

  • 24. Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
    Trautmann S; Wittchen HU
    Subst Use Misuse; 2012 Jan; 47(1):22-30. PubMed ID: 22060728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher methadone doses are associated with lower mortality in patients of opioid dependence in Taiwan.
    Liao DL; Chen PC; Chen CH; Hsieh CJ; Huang YF; Shih WY; Cheng JJ
    J Psychiatr Res; 2013 Oct; 47(10):1530-4. PubMed ID: 23880602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular-associated disease in an addicted population: an observation study.
    Demarie D; Marletta G; Imazio M; Cappa C; Ferro S; Compostino R; De Vivo E; Trinchero R; Bignamini E
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):51-4. PubMed ID: 21135593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of psychiatric severity on the outcome of methadone maintenance treatment.
    Pani PP; Maremmani I; Pacini M; Lamanna F; Maremmani AG; Dell'osso L
    Eur Addict Res; 2011; 17(2):80-9. PubMed ID: 21178355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ageing methadone population: A challenge for treating doctors.
    Nagarajan S; Wong A; Greene SL; Koutsogiannis Z
    Aust J Gen Pract; 2019 Mar; 48(3):111-112. PubMed ID: 31256476
    [No Abstract]   [Full Text] [Related]  

  • 30. New community-based methadone maintenance treatment programs in Guangdong, China, and their impact on patient quality of life.
    He Q; Wang X; Xia Y; Mandel JS; Chen A; Zhao L; Han L; Ling L
    Subst Use Misuse; 2011; 46(6):749-57. PubMed ID: 21114401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Family typology and deterioration related to opioids use, in a methadone treatment patients group].
    Garrido Fernández M; Torrado Val E; Marcos Sierra JA
    Actas Esp Psiquiatr; 2010; 38(4):196-203. PubMed ID: 21104464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.
    Carpentier PJ; van Gogh MT; Knapen LJ; Buitelaar JK; De Jong CA
    Eur Addict Res; 2011; 17(1):10-20. PubMed ID: 20881401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The science and practice of medication-assisted treatments for opioid dependence.
    Pecoraro A; Ma M; Woody GE
    Subst Use Misuse; 2012; 47(8-9):1026-40. PubMed ID: 22676570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to Bird et al.: The importance of post-release engagement in treatment in estimating impacts on post-release deaths.
    Larney S; Degenhardt L; Farrell M
    Addiction; 2016 Mar; 111(3):560-1. PubMed ID: 26589456
    [No Abstract]   [Full Text] [Related]  

  • 35. A Case of a Perinatal Woman on Methadone Maintenance Who Developed Postpartum Torsades de Pointes: Importance of Perinatal Changes in Drug Metabolism.
    Spiegel A; Spiegel DR; Byrd V; Hopkins K
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):484-487. PubMed ID: 34155161
    [No Abstract]   [Full Text] [Related]  

  • 36. Methadone maintenance treatment: coming of age in New Zealand.
    Sellman D; Deering D; Robinson G
    N Z Med J; 1995 Apr; 108(997):128-30. PubMed ID: 7739822
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal lipidosis in patients enrolled in a methadone substitution program.
    Porubsky S; Kuppe C; Maier T; Birk HW; Wörnle M; Moeller MJ; Floege J; Gröne HJ
    Arch Pathol Lab Med; 2014 May; 138(5):689-93. PubMed ID: 24786128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
    J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.